New GlyT2 blocker relieves chronic neuropathic pain without major side effects
Chronic neuropathic pain remains one of the most challenging conditions to treat, with current therapies offering limited benefit and being over-reliant on opioids. Researchers at Rensselaer Polytechnic Institute (RPI), along with collaborators from the University […]
